4//SEC Filing
MATEON THERAPEUTICS INC 4
Accession 0001209191-17-039317
$OTLCCIK 0000908259operating
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 8:29 PM ET
Size
5.9 KB
Accession
0001209191-17-039317
Insider Transaction Report
Form 4
Reynolds Donald Rogers
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-06-09+121,483→ 121,483 totalExercise: $0.51Exp: 2023-06-09→ Common Stock (121,483 underlying)
Footnotes (2)
- [F1]Mr. Reynolds was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per share (the "Stock Options"), in connection with his service as a member of the Board of Directors pursuant to the Mateon Therapeutics, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy.
- [F2]The Stock Options will vest in full on June 9, 2018, subject to Mr. Reynolds' continued service on the Board of Directors as of such date.
Documents
Issuer
MATEON THERAPEUTICS INC
CIK 0000908259
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000908259
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 8:29 PM ET
- Size
- 5.9 KB